U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261059) titled 'AI-assisted Integrated Care to Promote Colonoscopy Uptake' on Nov. 21.
Brief Summary: Colorectal cancer (CRC) ranks the second most common cancer and the fourth leading cause of cancer-related deaths in China. Early screening of CRC has been proven to reduce the incidence and mortality, with colonoscopy as the gold standard for CRC screening. This trial aims to evaluate the effectiveness of artificial intelligence-assistant integrated care for improving uptake rate of colonoscopy among high-risk individuals aged 40 to 64 in China. It's a two-arm, parallel cluster randomized controlled trial. The main question it aims to answer is whe...